A risk model predicts the risk for heart failure in patients with atherosclerotic cardiovascular disease and flags a notable ...

The US Food and Drug Administration (FDA) has granted Noah Labs breakthrough device designation for a remote patient ...

Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience ...

A large proportion of people living with diabetes may have undiagnosed heart failure, according to results from a recent ...

The results run counter to ABYSS but align with other data showing beta-blockers shouldn’t continue indefinitely after MI.

For decades, surviving a heart attack has come with a lifelong prescription: Stay on medications called beta-blockers to help protect your heart. But doctors are taking a closer look at whether ...

Among stable, relatively low-risk patients who had previously suffered a heart attack, discontinuing beta-blockers after at ...

At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received optimal medical therapy plus a minimally invasive procedure using a clip to repair the valve ...

Heart failure is a chronic and serious condition, where the heart muscle cannot pump blood properly. This causes fluid buildup (congestion) in the lungs or body. People often wonder what is the life ...

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary hypertension) experienced significant improvements in blood pressure and ...

Research involving 700 patients was led by the University of Glasgow.